Abstract
Treatment of lesions in small coronary vessels is associated with an increased risk of adverse cardiovascular events after PCI. We sought to compare the clinical and angiographic outcomes of patients with vs. without small-vessel PCI with contemporary DES in the BioNIR Ridaforolimus-eluting coronary
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
